These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 4110180

  • 1. [Modifications of fibrinolysis and coagulation activity in arteriosclerotic patients treated with a polysulfoester of pentosan (SP-54). I].
    Cajozzo A, Citarrella P, Malleo C.
    Boll Soc Ital Cardiol; 1971; 16(3):117-26. PubMed ID: 4110180
    [No Abstract] [Full Text] [Related]

  • 2. [Modifications of platelet adhesiveness and aggregation ability in atherosclerotics treated with a polysulfoester of pentosan (SP-54). II].
    Cajozzo A, Citarrella P, Carreca I.
    Boll Soc Ital Cardiol; 1971; 16(3):127-34. PubMed ID: 4110181
    [No Abstract] [Full Text] [Related]

  • 3. [Modifications of the renogram and scansiometry with hippuran-I 131 and chlormerodrin-Hg 203 , studied with Pho Gamma 3, in arteriosclerosis treated with polysulfoester of pentosan (SP-54)].
    Indovina I, Salerno L, Licata G.
    Boll Soc Ital Cardiol; 1971; 16(4):173-83. PubMed ID: 4110135
    [No Abstract] [Full Text] [Related]

  • 4. [Electrocardiographic and rheographic modifications in arteriosclerotics treated with polysulfoester of pentosan (SP-54)].
    Aguglia V, Sgroi C, Cerasola GA.
    Boll Soc Ital Cardiol; 1972; 17(2):65-75. PubMed ID: 5071185
    [No Abstract] [Full Text] [Related]

  • 5. [Modification of periferal diffusion curves with albumin-I 131 at rest and after muscular effort in arteriosclerotics after treatment with polysulfoester of pentosan (SP-54)].
    Indovina I, Licata G, Salerno L.
    Boll Soc Ital Cardiol; 1971; 16(4):157-71. PubMed ID: 4110134
    [No Abstract] [Full Text] [Related]

  • 6. [Controlled experimental study of the relations between fibrinolytic acitivity and anticoagulant activity in evaluation of activators of fibrinolysis].
    Cascone A, Lampugnani P.
    Minerva Med; 1969 Dec 12; 60(99 Suppl):5039-45. PubMed ID: 4188588
    [No Abstract] [Full Text] [Related]

  • 7. [Study on the effect of a pentosan polysulfoester on blood coagulation and fibrinolysis].
    Henk W, Nebosis G.
    Wien Klin Wochenschr; 1968 Mar 08; 80(10):191-4. PubMed ID: 5650711
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Antilipemic and fibrinolytic activity of an extractive mucopolysaccharide in atherosclerotic disease].
    Isidori A, Butti A, Rossi G.
    Minerva Med; 1969 Dec 12; 60(99 Suppl):5077-81. PubMed ID: 4188592
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical evaluation of a fribrinolytic drug in an experimental cross-over study].
    Bizzi B, Butti A.
    Minerva Med; 1969 Dec 12; 60(99 Suppl):5062-7. PubMed ID: 4188590
    [No Abstract] [Full Text] [Related]

  • 11. Preangioplasty fibrinolytic therapy using SP-54 including acute and subacute occlusions.
    Haapanen A, Leinonen A, Seppänen S.
    Ann Radiol (Paris); 1984 Dec 12; 27(4):340. PubMed ID: 6204575
    [No Abstract] [Full Text] [Related]

  • 12. [Electroencephalographic and audiometric controls in presenile and senile arteriosclerotic subjects treated with an extractive sulfomucopolysaccharide complex with fibrinolytic action].
    Sfondrini E, Barberi G.
    Minerva Med; 1969 Dec 12; 60(99 Suppl):5082-6. PubMed ID: 4188593
    [No Abstract] [Full Text] [Related]

  • 13. [Study of the activity of a sulfomucopolysaccharide extractive on the blood-lipid and fibrinolytic pattern in atherosclerotic disease].
    Isidori A, Recchia O, Butti A.
    Minerva Med; 1967 Mar 07; 58(19):779-82. PubMed ID: 4164416
    [No Abstract] [Full Text] [Related]

  • 14. Fibrinolytic effects of defibrotide in atherosclerotic patients.
    Patrassi GM, Sartori MT, Viero ML, Scapinello MP, Boeri G, Girolami A.
    Semin Thromb Hemost; 1991 Mar 07; 17 Suppl 1():101-5. PubMed ID: 2068562
    [Abstract] [Full Text] [Related]

  • 15. Study of serum lipid fractions as related to blood coagulation, fibrinolysis and platelet aggregation in cholesterol fed rabbits and in arteriosclerotic patients given clofibrate.
    Baldoni E, Egge H, Cuttin S, Murawski U, Gibelli A, Giarola P.
    Farmaco Sci; 1973 Sep 07; 28(9):713-21. PubMed ID: 4749857
    [No Abstract] [Full Text] [Related]

  • 16. [The treatment of myocardial infarct with a drug activating fibrinolysis (pentosane sulfuric polyester, SP 54) administered in slow venous infusion].
    Marangoni R, Ferrari A, Brera V.
    Minerva Cardioangiol; 1967 Jan 07; 15(1):45-50. PubMed ID: 4174894
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Study of clofibrate in hypercholesterinemic rabbits and in arteriosclerotic subjects-modifications of platelet aggregation and fibrinolysis as related to lipidic fractions.
    Baldoni F, Egge H, Giarola P, Müller H, Cuttin S, Gibelli A, Zilliken F, de Nicola P.
    New Istanbul Contrib Clin Sci; 1972 Dec 07; 10(3):135-8. PubMed ID: 4670445
    [No Abstract] [Full Text] [Related]

  • 19. [Pharmacological aspects of fibrinolysis].
    Prino G, Mantovani M.
    Boll Chim Farm; 1969 Dec 07; 108(12):727-60 passimf. PubMed ID: 4911753
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of pyridinolcarbamate on blood coagulation and thrombolysis in patients with arteriosclerosis obliterans].
    Hess H, Goossens N, Keil-Kuri E, Zollner R, Meyer A.
    Vasa; 1972 Dec 07; 1(3):206-11. PubMed ID: 5076123
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.